<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940202-2-00102</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=11 g=1 f=1 --> NNIS reports that pneumonias (diagnosed on the basis of the CDC surveillance definition of nosocomial pneumonia) and surgical-wound infections account for approximately 15% each of all hospital-associated infections and are the second most common nosocomial infections after that of the urinary tract. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 3 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  In 1984, the overall incidence of lower respiratory tract infection was 6 per 1,000 discharged patients. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 3 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  The incidence ranged from 4.2 to 7.7 per 1,000 discharged patients for nonteaching and university-affiliated hospitals, respectively, probably reflecting institutional differences in the level of patients' risk for acquiring nosocomial pneumonia.  <!-- PJG 0012 frnewline --> Nosocomial bacterial pneumonia often has been identified as a postoperative infection. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 59,60 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  In the Study of the Efficacy of Nosocomial Infection Control in the 1970s, 75% of reported cases of nosocomial bacterial pneumonia occurred in patients who had had a surgical operation; the risk was 38 times greater for thoracoabdominal procedures than for those involving other body sites. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 60 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  More recent epidemiologic studies, including NNIS studies, have identified other subsets of patients at high risk of developing nosocomial bacterial pneumonia: Patients with endotracheal intubation and/or mechanically assisted ventilation, depressed level of consciousness (particularly those with closed-head injury), prior episode of a large-volume aspiration, or underlying chronic lung disease, and patients >70 years of age. Other risk factors include 24-hour ventilator-circuit changes, fall-winter season, stress-bleeding prophylaxis with cimetidine with or without antacid, presence of a nasogastric tube, severe trauma, and recent bronchoscopy. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 7,34,35,61&hyph;69 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->   <!-- PJG 0012 frnewline --> Recently, NNIS stratified the incidence density of nosocomial pneumonia by patients' use of mechanical ventilator and type of intensive care unit (ICU). From 1986 to 1990, the median rate of ventilator-associated pneumonia per 1,000 ventilator-days ranged from 4.7 in pediatric ICUs to 34.4 in burn ICUs. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 63 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  In contrast, the median rate of nonventilator-associated pneumonia per 1000 ICU-days ranged from 0 in pediatric and respiratory ICUs to 3.2 in trauma ICUs.  <!-- PJG 0012 frnewline --> Nosocomial pneumonia has been associated with high fatality rates. Crude mortality rates of 20%&hyph;50% and attributable mortality rates of 30%&hyph;33% have been reported; in one study, pneumonia comprised 60% of all deaths due to nosocomial infections. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 18,35,70&hyph;75 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  Patients receiving mechanically assisted ventilation have higher mortality rates than patients not receiving ventilation support; however, other factors, such as a patient's underlying disease(s) and organ failure, are stronger predictors of death in patients with pneumonia. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 34 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->   <!-- PJG 0012 frnewline --> Pneumonia-associated morbidity has not been evaluated in recent years. Past studies, however, have shown that pneumonia could prolong hospitalization by 4&hyph;9 days. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 74&hyph;77 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  A conservative estimate of the direct cost of excess hospital stay due to pneumonia is $1.1 billion a year for the nation. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 78 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  Because of its reported frequency, associated high fatality rate, and attendant costs, nosocomial pneumonia is a major infection control problem.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> IV. Pathogenesis  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Bacteria may invade the lower respiratory tract by aspiration of oropharyngeal organisms, inhalation of aerosols containing bacteria, or less frequently, by hematogenous spread from a distant body site (Figure 1). In addition, bacterial translocation from the gastrointestinal tract has been recently hypothesized as a mechanism for infection. Of these routes, aspiration is believed to be the most important for both nosocomial and community-acquired pneumonia.  <!-- PJG 0012 frnewline --> In radioisotope-tracer studies of healthy adults, 45% were found to aspirate during sleep. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 79 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  Persons with abnormal swallowing, such as those who have depressed consciousness, respiratory tract instrumentation and/or mechanically assisted ventilation, gastrointestinal tract instrumentation or diseases, or have just undergone surgery, are particularly likely to aspirate. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 7,34,35,60,80 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->   <!-- PJG 0012 frnewline --> The high incidence of gram-negative bacillary pneumonia in hospitalized patients appears to be the result of factors that promote colonization of the pharynx by gram-negative bacilli and the subsequent entry of these organisms into the lower respiratory tract. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 33,81&hyph;84 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  Whereas aerobic gram-negative bacilli are recovered infrequently or are found in small numbers in pharyngeal cultures of healthy persons, <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 81,85 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  colonization dramatically increases in patients with coma, hypotension, acidosis, azotemia, alcoholism, diabetes mellitus, leukocytosis, leukopenia, pulmonary disease, nasogastric or endotracheal tubes in place, and in patients given antimicrobial agents. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 33,84,86,87 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->   <!-- PJG 0012 frnewline --> Oropharyngeal or tracheobronchial colonization by gram-negative bacilli begins with the adherence of the microorganisms to the host's epithelial cells. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 83,88&hyph;90 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  Adherence may be affected by multiple factors related to the bacteria (presence of pili, cilia, capsule, or production of elastase or mucinase), host cell (surface proteins and polysaccharides), and environment (pH and presence of mucin in respiratory secretions). <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 82,83,88,91&hyph;100 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  The exact interactions among these factors have not been fully elucidated, but studies indicate that certain substances, such as fibronectin, can inhibit the adherence of gram-negative bacilli to host cells. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 91,93,101 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  Conversely, certain conditions, such as malnutrition, severe illness, or post-operative state, can increase adherence of gram-negative bacteria. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 82,91,95,100,102 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->   <!-- PJG 0012 frnewline --> Besides the oropharynx, the stomach has been postulated to be an important reservoir of organisms that cause nosocomial pneumonia. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 34,103&hyph;107 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  The stomach's role may vary depending on the patient's underlying conditions and on prophylactic or therapeutic interventions. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 22,104,108&hyph;111 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  In healthy persons, few bacteria entering the stomach survive in the presence of hydrochloric acid at pH&lt;2. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 112,113 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  However, when gastric pH increases from the normal levels to >4, microorganisms are able to multiply to high concentrations in the stomach. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 110,112,114&hyph;116 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  This can occur in patients with advanced age, <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 114 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  achlorhydria, <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 112 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  ileus, or upper gastrointestinal disease, and in patients receiving enteral feeding, antacids, or histamine-2 [H&hyph;2] antagonists. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 104,110,111,116&hyph;118 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  The contribution of other factors, such as duodeno-gastric reflux and the presence of bile, to gastric colonization in patients with impaired intestinal motility has been suggested and needs further investigation. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 109 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->   <!-- PJG 0012 frnewline --> Bacteria can also gain entry into the lower respiratory tract of hospitalized patients through inhalation of aerosols generated primarily by contaminated respiratory-therapy or anesthesia-breathing equipment. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 119&hyph;122 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  Outbreaks related to the use of respiratory-therapy equipment have been associated with contaminated nebulizers, which are humidification devices that produce large amounts of aerosol droplets &lt;4&mu;m via ultrasound, spinning disk, or the Venturi mechanism. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 119,122,123 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  When the fluid in the reservoir of a nebulizer becomes contaminated with bacteria, the aerosol produced may contain high concentrations of bacteria that can be deposited deep in the patient's lower respiratory tract. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 119,123,124 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  Because endotracheal and tracheal tubes provide direct access to the lower respiratory tract, contaminated aerosol inhalation is particularly hazardous for intubated patients. In contrast to nebulizers, bubble-through or wick humidifiers mainly increase the water-vapor (or molecular-water) content of inspired gases. Although heated bubble-through humidifiers generate aerosol droplets, they do so in quantities that may not be clinically significant; <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 120,125 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  wick humidifiers do not generate aerosols.  <!-- PJG 0012 frnewline --> Rarely, bacterial pneumonia can result from hematogenous spread of infection to the lung from another infection site, e.g., pneumonia resulting from purulent phlebitis or right-sided endocarditis. Another mechanism, translocation of bacteria via the passage of viable bacteria from the lumen of the gastrointestinal tract through epithelial mucosa to the mesenteric lymph nodes and to the lung has been shown in animal models. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 126 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  Translocation is postulated to occur in patients with immunosuppression, cancer or burns; <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 126 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  however data are lacking regarding this mechanism in humans. <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=1 --> 127 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->   <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            